Next Article in Journal
N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide
Next Article in Special Issue
1-Phenyl-3-tosyl-1H-pyrrole
Previous Article in Journal
Synthesis and Pharmacological Evaluation of (+)-Usnic Acid Derivatives as Hypoglycemic Agents
Previous Article in Special Issue
Ferrocenyl-bis-(1-(4-benzyl-5-morpholinooxazol-2-yl)-N-(4-(trifluoromethyl)benzyl)methanamine)
 
 
Short Note

Article Versions Notes

Molbank 2022, 2022(4), M1460; https://doi.org/10.3390/M1460
Action Date Notes Link
article xml file uploaded 9 October 2022 06:38 CEST Original file -
article xml uploaded. 9 October 2022 06:38 CEST Update https://www.mdpi.com/1422-8599/2022/4/M1460/xml
article pdf uploaded. 9 October 2022 06:38 CEST Version of Record https://www.mdpi.com/1422-8599/2022/4/M1460/pdf-vor
article supplementary file uploaded. 9 October 2022 06:39 CEST - https://www.mdpi.com/1422-8599/2022/4/M1460#supplementary
article html file updated 9 October 2022 06:39 CEST Original file -
article pdf uploaded. 9 October 2022 10:15 CEST Updated version of record https://www.mdpi.com/1422-8599/2022/4/M1460/pdf
article html file updated 28 February 2023 17:11 CET Update -
article html file updated 1 March 2023 20:16 CET Update https://www.mdpi.com/1422-8599/2022/4/M1460/html
Back to TopTop